Charles Robertson II

Stock Analyst at Cantor Fitzgerald

(2.31)
# 2,612
Out of 5,124 analysts
3
Total ratings
100%
Success rate
13.45%
Average return

Stocks Rated by Charles Robertson II

Fennec Pharmaceuticals
Apr 6, 2023
Maintains: Overweight
Price Target: $12$16
Current: $7.70
Upside: +107.79%
ConocoPhillips
Dec 12, 2016
Upgrades: Outperform
Price Target: $47$59
Current: $93.61
Upside: -36.97%